Postischemic treatment (2–4 h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2 h) focal cerebral ischemia in the rat
- 6 November 1995
- journal article
- Published by Elsevier in Brain Research
- Vol. 698 (1-2) , 79-85
- https://doi.org/10.1016/0006-8993(95)00830-j
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats.Stroke, 1994
- Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.Stroke, 1992
- Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons.Stroke, 1992
- Monoclonal leukocyte antibody does not decrease the injury of transient focal cerebral ischemia in cats.Stroke, 1992
- Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons.Stroke, 1991
- Leukocyte adhesion in host defense and tissue injuryClinical Immunology and Immunopathology, 1991
- Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment.Stroke, 1991
- Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion.Stroke, 1989
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period.Stroke, 1986